While Wall Street insiders enjoyed a first day "pop," it appears Circle could have pocketed much more from its debut.

Goldman Sachs on Friday reviewed the generic drug industry, initiating the coverage of Teva Pharmaceutical (NYSE:TEVA) and Amneal Pharmaceuticals (NASDAQ:AMRX) with Buy ratings and Viatris ...

Shares of DocuSign tanked 18% in trading Friday, a day after the e-signature provider reported stronger-than-expected earnings but slashed its full-year billings outlook. Here's how the company ...